Vanda Q3 Earnings Snapshot
VNDA Stock | USD 4.69 0.09 1.96% |
About 68 percent of all Vanda Pharmaceuticals' investors are curious in acquiring. The analysis of the overall investor sentiment regarding Vanda Pharmaceuticals suggests that a large number of traders are confidant. The current market sentiment, together with Vanda Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Vanda Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Vanda |
WASHINGTON Vanda Pharmaceuticals Inc. VNDA on Wednesday reported a loss of 5.3 million in its third quarter. The Washington-based company said it had a loss of 9 cents per share.
Read at finance.yahoo.com
![]() |
Vanda Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Vanda Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Vanda Pharmaceuticals Fundamental Analysis
We analyze Vanda Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vanda Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vanda Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Vanda Pharmaceuticals is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Vanda Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vanda Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Vanda Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Vanda Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Vanda Pharmaceuticals Related Equities
CYTK | Cytokinetics | 0.47 | ||||
ANNX | Annexon | 0.45 | ||||
TSVT | 2Seventy Bio | 0.20 | ||||
REPL | Replimune | 0.57 | ||||
GPCR | Structure Therapeutics | 0.85 | ||||
LEGN | Legend Biotech | 0.93 | ||||
LQDA | Liquidia Technologies | 0.98 | ||||
BPMC | Blueprint Medicines | 1.13 | ||||
PHAT | Phathom Pharmaceuticals | 1.35 | ||||
PCVX | Vaxcyte | 1.85 | ||||
BMRN | Biomarin Pharmaceutical | 1.91 | ||||
RVMD | Revolution Medicines | 1.97 | ||||
TECH | Bio Techne | 2.04 | ||||
NUVB | Nuvation Bio | 2.67 | ||||
STOK | Stoke Therapeutics | 3.22 | ||||
CGEM | Cullinan Oncology | 3.26 | ||||
RCUS | Arcus Biosciences | 3.77 | ||||
KZR | Kezar Life | 4.09 | ||||
TIL | Instil Bio | 6.61 | ||||
RLAY | Relay Therapeutics | 9.03 | ||||
CNTB | Connect Biopharma | 10.53 |
Complementary Tools for Vanda Stock analysis
When running Vanda Pharmaceuticals' price analysis, check to measure Vanda Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vanda Pharmaceuticals is operating at the current time. Most of Vanda Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vanda Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vanda Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vanda Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Stocks Directory Find actively traded stocks across global markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |